We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2876
Sutro Biopharma
STRO
$190M
| $1.36K | ﹤0.01% |
47
| – | – |
2021 Q1
13 quarters
|
|
2877
Northwest Natural Holdings
NWN
$2.04B
| $1.36K | ﹤0.01% |
38
-28
| -42% | -$1.03K |
2021 Q2
12 quarters
|
|
2878
Albany International
AIN
$1.72B
| $1.36K | ﹤0.01% |
16
-4
| -20% | -$349 |
2021 Q2
12 quarters
|
|
2879
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $1.36K | ﹤0.01% |
+191
| New | +$1.54K |
2024 Q2
0 quarters
|
|
2880
Invesco Pharmaceuticals ETF
PJP
$559M
| $1.33K | ﹤0.01% |
16
| – | – |
2023 Q3
3 quarters
|
|
2881
DELISTED
The First Bancshares, Inc.
FBMS
| $1.32K | ﹤0.01% |
+51
| New | +$1.26K |
2024 Q2
0 quarters
|
|
2882
Miller Industries
MLR
$582M
| $1.32K | ﹤0.01% |
24
| – | – |
2023 Q3
3 quarters
|
|
2883
ACV Auctions
ACVA
$1.78B
| $1.31K | ﹤0.01% |
72
+46
| +177% | +$827 |
2023 Q4
2 quarters
|
|
2884
ProPetro Holding
PUMP
$975M
| $1.31K | ﹤0.01% |
+151
| New | +$1.35K |
2024 Q2
0 quarters
|
|
2885
DELISTED
Heidrick & Struggles
HSII
| $1.29K | ﹤0.01% |
+41
| New | +$1.34K |
2024 Q2
0 quarters
|
|
2886
Northern Dynasty Minerals
NAK
$515M
| $1.29K | ﹤0.01% |
4,150
| – | – |
2020 Q3
15 quarters
|
|
2887
Verrica Pharmaceuticals
VRCA
$64.9M
| $1.28K | ﹤0.01% |
+18
| New | +$1.38K |
2024 Q2
0 quarters
|
|
2888
Revolution Medicines
RVMD
$40.6B
| $1.28K | ﹤0.01% |
+33
| New | +$1.23K |
2024 Q2
0 quarters
|
|
2889
Provident Financial Services
PFS
$2.9B
| $1.26K | ﹤0.01% |
+88
| New | +$1.28K |
2024 Q2
0 quarters
|
|
2890
IES Holdings
IESC
$11.1B
| $1.25K | ﹤0.01% |
+18
| New | +$1.26K |
2024 Q2
0 quarters
|
|
2891
Standard Lithium
SLI
$343M
| $1.25K | ﹤0.01% |
1,000
| – | – |
2021 Q4
10 quarters
|
|
2892
Hudson Technologies
HDSN
$212M
| $1.25K | ﹤0.01% |
142
-86
| -38% | -$833 |
2022 Q3
7 quarters
|
|
2893
First Trust Senior Loan Fund ETF
FTSL
$2.49B
| $1.23K | ﹤0.01% |
+27
| New | +$1.25K |
2024 Q2
0 quarters
|
|
2894
ALX Oncology
ALXO
$138M
| $1.23K | ﹤0.01% |
204
| – | – |
2023 Q3
3 quarters
|
|
2895
High Templar Tech Ltd
HTT
$332M
| $1.23K | ﹤0.01% |
620
+356
| +135% | +$743 |
2024 Q1
1 quarter
|
|
2896
KKR Real Estate Finance Trust
KREF
$350M
| $1.22K | ﹤0.01% |
135
-258
| -66% | -$2.46K |
2022 Q4
6 quarters
|
|
2897
Simmons First National
SFNC
$3.22B
| $1.21K | ﹤0.01% |
69
| – | – |
2017 Q3
27 quarters
|
|
2898
DELISTED
Arcadium Lithium plc
ALTM
| $1.21K | ﹤0.01% |
360
-55
| -13% | -$230 |
2024 Q1
1 quarter
|
|
2899
N-able
NABL
$869M
| $1.2K | ﹤0.01% |
+79
| New | +$1.04K |
2024 Q2
0 quarters
|
|
2900
Adtran
ADTN
$532M
| $1.2K | ﹤0.01% |
228
+172
| +307% | +$876 |
2023 Q1
5 quarters
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.